- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
February 26, 2013 (HealthDay News) -- There's no firm evidence that the type 2 diabetes medications known as incretin-based drugs cause pancreatitis or pancreatic cancer, U.S. and European health officials say.
But it's too early to say there's definitely no link between the injectable drugs and pancreatitis or pancreatic cancer, according to the s
February 12, 2014 (HealthDay News) -- Although it's a common belief that a diagnosis of type 2 diabetes often follows a large weight gain, a new study challenges that notion.
Researchers found that the majority of people diagnosed with type 2 diabetes didn't get the disease until they'd been overweight or obese for a number of years.
What's more, participants who maintained stable levels of overweight and eventually developed type 2 diabetes didn't have a significant rise in their l
February 6, 2014 (Newswise) -- Infection is a stronger trigger of stroke death in African- Americans than in whites, a University of Michigan study shows.
African-Americans were 39 times more likely to die of a stroke if they were exposed to an infection in the previous month when compared to other time periods while whites were four times more likely and Hispanics were five times more likely to die of stroke after an infection, according to the findings that appear online Feb. 7 in
February 10, 2014 (MedwireNews) -- Very intensive control of blood pressure (BP) in patients with Type 2 diabetes does not prevent cognitive decline and may even be counterproductive, suggest findings from the ACCORD MIND substudy.
The MIND (Memory in Diabetes) substudy tracked the cognition and total brain volume of a group of participants in ACCORD (Action to Control Cardiovascular Risk in Diabetes), which investigated the effects of int
Oramed Submits Phase 2a Protocol to FDA for the Treatment of Type 1 Diabetes with its Oral Insulin Capsule
February 10, 2014 (PRNewswire) -- Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted a protocol to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2a trial of its orally ingestible insu